Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Gilead Sciences, Inc.    GILD   US3755581036

GILEAD SCIENCES, INC. (GILD)

292
SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll news 

Gilead Sciences, Inc. : FDA Panel Backs Gilead's HIV 'Quad' Medicine

05/11/2012 | 03:06pm US/Eastern
   By Jennifer Corbett Dooren 
   Of  
 

A federal advisory panel Friday backed an experimental Gilead Sciences Inc. (GILD) HIV medicine known as the Quad.

The company is seeking approval from the Food and Drug Administration to market the product, which combines four active ingredients into one pill, meant to be taken once daily.

The medicine was reviewed on Friday by the agency's antiviral drugs advisory panel, which is made up of non-FDA medical experts. The panel voted 13 to 1 on a question that asked if the submitted clinical data supported approval of the drug. The panel vote amounts to a recommendation that the FDA approve the drug. The agency usually follows panel recommendations but isn't required to. The FDA is expected to make a decision by the end of August.

Quad is a combination of four active ingredients in one pill. It combines Gilead's double-drug Truvada, the drug elvitegravir and an agent that boosts blood levels of certain HIV drugs, cobicistat.

Gilead is hoping that the one-pill, once-daily Quad regimen will provide more convenience to HIV patients, many of whom now take multiple pills for treatment. Some analysts think it could become a blockbuster seller.

-By Jennifer Corbett Dooren; Dow Jones Newswires, 202-862-9294; jennifer.corbett@dowjones.com

Latest news on GILEAD SCIENCES, INC.
6h ago GILEAD SCIENCES : Yale and Gilead Sciences Extend Cancer Research Collaboration
1d agoGILEAD SCIENCES, INC. : quaterly earnings release
2d ago GILEAD SCIENCES : Prime Therapeutics responds to FDA approval of Gilead's latest..
2d ago GILEAD SCIENCES : Health Canada Issues Notice of Compliance for Gilead's Harvoni..
2d ago GILEAD SCIENCES : Breaks Ground On R%7ED Facility In Edmonton
3d ago GILEAD SCIENCES : to Release Third Quarter 2014 Financial Results on Tuesday, Oc..
3d ago GILEAD SCIENCES : Gets Notice of Compliance for Harvoni
3d ago GILEAD SCIENCES : Health Canada Issues Notice of Compliance for Gilead's Harvoni
3d ago GILEAD SCIENCES : Harvoni Garners Health Canada Notice of Compliance
10/16 GILEAD SCIENCES : Health Canada issues notice of compliance for Gilead's Harvoni..
Advertisement
Chart
Duration : Period :
Gilead Sciences, Inc. Technical Analysis Chart | GILD | US3755581036 | 4-Traders
Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF